Leap Therapeutics, Inc.
LPTX
$0.2963
-$0.0137-4.42%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 18.26% | -11.69% | -25.67% | -32.71% | -52.07% |
| Total Depreciation and Amortization | -- | -- | -100.00% | -100.00% | 100.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -5.59% | -3.37% | 356.56% | -23.78% | 2.29% |
| Change in Net Operating Assets | -88.94% | 88.16% | -205.90% | -13.54% | 204.51% |
| Cash from Operations | -5.96% | 6.68% | -49.44% | -48.74% | -34.23% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -100.00% | -44.83% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -100.32% | -310.34% | -- | -6,500.00% | -- |
| Foreign Exchange rate Adjustments | -80.36% | 102.13% | -159.29% | 105.46% | 224.44% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -161.90% | 7.54% | -54.20% | -46.70% | 321.76% |